New study tests Brain-Saving drugs for stroke patients
NCT ID NCT07260760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well certain drugs protect the brain after a mild to moderate stroke. Researchers will follow 600 adults who had a stroke within the last 48 hours and received edaravone or dexrazoxane. The goal is to see if these drugs help patients recover better and are worth the cost.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?